Humana reiterates FY2026 targets and declares $0.885 dividend
Humana reiterated FY2026 GAAP EPS ≥ $6.52 and adjusted EPS ≥ $9.00, declared a $0.885/share dividend (record Oct 30, pay Nov 27), and scheduled September investor meetings.
Humana Inc. reiterated its FY2026 targets for GAAP EPS of at least 6.52 and adjusted EPS of at least 9.00, and said it will hold investor meetings in September. The company also declared a dividend of 0.885 per share, with a record date of Oct 30 and payment on Nov 27. In addition, Humana said it partnered with Mark Cuban Cost Plus Drug Co.
through SwiftyRx and backed Thyme Care’s Series E.